Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > JP Morgan update

<< Previous

Bullboard Posts

Next >>

Post by BioTeckon Jan 05, 2022 10:06am

581 Views

Post# 34284767

JP Morgan update

So much interest, like never before. Phil is scheduled for one on ones with 6 big biotech companies right now. Meetings scheduled with all the CEO's over the next week. They all want a piece. Just a matter of time before we are bought out. 5 Big deals all complete and just waiting to be signed. These big firms move so slow you know. Hey gotta go, my cell phone is dying, got lots of calls to make and in meetings with CEOs of big pharma all day.

Here is a little preview of Selphies monday update.

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record